                         SEQUENCE LISTING

<110>  Univeristy of North Carolina at Chapel Hill
       Williams, David
       Waters, Marcey  L.
       St. Louis, Lauren E.
       Krajewski, Krzysztof  E.
 
<120>  COMPOSITIONS AND METHODS FOR TARGETING THE NUCLEOSOME REMODELING 
       AND DEACETYLASE COMPLEX

<130>  421/458 PCT

<150>  US 62/861,464
<151>  2019-06-14

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  27
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (2)..(2)
<223>  Norleucine

<400>  1

Tyr Xaa Ile Lys Gln Leu Lys Glu Glu Leu Arg Leu Glu Glu Ala Lys 
1               5                   10                  15      


Leu Val Leu Leu Lys Lys Leu Arg Gln Ser Gln 
            20                  25          


<210>  2
<211>  33
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  2

Lys Lys Lys Arg Lys Val Tyr Ala Ile Lys Gln Leu Lys Cys Glu Leu 
1               5                   10                  15      


Arg Cys Glu Glu Ala Lys Leu Val Leu Leu Lys Lys Leu Arg Gln Ser 
            20                  25                  30          


Gln 
    


<210>  3
<211>  31
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  X
<222>  (2)..(2)
<223>  Beta Alanine

<220>
<221>  X
<222>  (3)..(4)
<223>  Ornithine

<220>
<221>  X
<222>  (6)..(6)
<223>  Norleucine

<400>  3

Tyr Xaa Xaa Xaa Gly Xaa Ile Lys Gln Leu Lys Cys Glu Leu Arg Cys 
1               5                   10                  15      


Glu Glu Ala Lys Leu Val Leu Leu Lys Lys Leu Arg Gln Ser Gln 
            20                  25                  30      


<210>  4
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (9)..(9)
<223>  Norleucine

<400>  4

Lys Lys Lys Arg Lys Val Tyr Gly Xaa Ile Lys Gln Leu Lys Cys Glu 
1               5                   10                  15      


Leu Arg Cys Glu Glu Ala Lys Leu Val Leu Leu Lys Lys Leu Arg Gln 
            20                  25                  30          


Ser Gln 
        


<210>  5
<211>  35
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  X
<222>  (10)..(10)
<223>  Norleucine

<400>  5

Gly Lys Lys Lys Arg Lys Val Tyr Gly Xaa Ile Lys Gln Leu Lys Cys 
1               5                   10                  15      


Glu Leu Arg Cys Glu Glu Ala Lys Leu Val Leu Leu Lys Lys Leu Arg 
            20                  25                  30          


Gln Ser Gln 
        35  


<210>  6
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  X
<222>  (9)..(9)
<223>  Norleucine

<400>  6

Lys Lys Lys Arg Lys Val Tyr Gly Xaa Ile Lys Gln Leu Lys Glu Glu 
1               5                   10                  15      


Leu Arg Leu Glu Glu Ala Lys Leu Val Leu Leu Lys Lys Leu Arg Gln 
            20                  25                  30          


Ser Gln 
        


<210>  7
<211>  34
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  X
<222>  (9)..(9)
<223>  Norleucine

<400>  7

Lys Lys Lys Arg Lys Val Tyr Gly Xaa Gly Lys Gln Gly Lys Glu Glu 
1               5                   10                  15      


Gly Arg Leu Glu Glu Ala Lys Gly Val Leu Gly Lys Lys Leu Arg Gln 
            20                  25                  30          


Ser Gln 
        


